1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow amprenavir: new trials by email Literature Review of amprenavir trials Research Report on amprenavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) Lamivudine, Stavudine, Didanosine - HIV-Associated Lipodystrophy Syndrome, Cardiovascular Disease | Phase 4 | Completed | Kirby Institute | 80 | 2003-02-01 | 2012-04-12 |
| Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment Ritonavir, Abacavir sulfate, Amprenavir - HIV Infections | Phase 4 | Unknown | Glaxo Wellcome | 300 | 2005-06-24 |
HIV Infections (2) · Cardiovascular Diseases (1) · HIV-Associated Lipodystrophy Syndrome (1) · Lipodystrophy (1)
Glaxo Wellcome (1) · Kirby Institute (1)
Australia (1) · United States (1)
Andrew D Carr, MD (1) · David A Cooper, MD (1)
R01HL065953 (1)